Amneal Pharmaceuticals Outperforms Medical Sector YTD, Biohaven Ltd. Also Exceeds

jueves, 22 de enero de 2026, 11:22 am ET1 min de lectura
AMRX--
BHVN--

Amneal Pharmaceuticals (AMRX) has outperformed the medical sector this year, with an 8.8% gain compared to the sector's 7.6% average. The company has a Zacks Rank of #2 (Buy) and its full-year earnings estimate has increased 5.6% in the past 90 days. Biohaven Ltd. (BHVN) is another medical stock that has outperformed the sector with a 14% gain this year.

Amneal Pharmaceuticals Outperforms Medical Sector YTD, Biohaven Ltd. Also Exceeds

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios